Leukocare

About Leukocare

Leukocare AG, based in Munich, Germany, specializes in advanced formulation technologies aimed at stabilizing and protecting biologics, such as therapeutic proteins, antibodies, and vaccines. The company operates in the biotechnology sector, serving pharmaceutical and biotech companies that require enhanced stability and performance for their biologic products. Leukocare's proprietary technology platform, SPS (Stabilizing and Protecting Solutions), enables the development of both dry and liquid formulations, significantly improving the shelf life and efficacy of biologics. The business model is centered around partnerships and collaborations, where Leukocare provides its formulation expertise and technology to integrate into the products of its partners. Revenue is generated through service fees, licensing agreements, and milestone payments. The company also adheres to stringent quality management standards, including EN ISO 13485 and EN ISO 9001, ensuring high-quality and compliant solutions.